449 related articles for article (PubMed ID: 12700180)
1. Bone morphogenetic proteins, their antagonists, and the skeleton.
Canalis E; Economides AN; Gazzerro E
Endocr Rev; 2003 Apr; 24(2):218-35. PubMed ID: 12700180
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins and their antagonists.
Gazzerro E; Canalis E
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):51-65. PubMed ID: 17029022
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation.
van der Horst G; van Bezooijen RL; Deckers MM; Hoogendam J; Visser A; Löwik CW; Karperien M
Bone; 2002 Dec; 31(6):661-9. PubMed ID: 12531559
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein signal transduction in bone.
ten Dijke P
Curr Med Res Opin; 2006; 22 Suppl 1():S7-11. PubMed ID: 16882364
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for the action of bone morphogenetic proteins and regulation of their activity.
Ebara S; Nakayama K
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S10-5. PubMed ID: 12205413
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.
Suzawa M; Takeuchi Y; Fukumoto S; Kato S; Ueno N; Miyazono K; Matsumoto T; Fujita T
Endocrinology; 1999 May; 140(5):2125-33. PubMed ID: 10218963
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
[TBL] [Abstract][Full Text] [Related]
9. BMP and BMP inhibitors in bone.
Rosen V
Ann N Y Acad Sci; 2006 Apr; 1068():19-25. PubMed ID: 16831902
[TBL] [Abstract][Full Text] [Related]
10. Potential drug targets within bone morphogenetic protein signaling pathways.
Gazzerro E; Minetti C
Curr Opin Pharmacol; 2007 Jun; 7(3):325-33. PubMed ID: 17475557
[TBL] [Abstract][Full Text] [Related]
11. The Bone Morphogenetic Proteins and Their Antagonists.
Mulloy B; Rider CC
Vitam Horm; 2015; 99():63-90. PubMed ID: 26279373
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair.
Yu YY; Lieu S; Lu C; Miclau T; Marcucio RS; Colnot C
Bone; 2010 Mar; 46(3):841-51. PubMed ID: 19913648
[TBL] [Abstract][Full Text] [Related]
13. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN.
Reddi AH
Arthritis Res; 2001; 3(1):1-5. PubMed ID: 11178121
[TBL] [Abstract][Full Text] [Related]
14. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
[TBL] [Abstract][Full Text] [Related]
15. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation.
Korchynskyi O; Dechering KJ; Sijbers AM; Olijve W; ten Dijke P
J Bone Miner Res; 2003 Jul; 18(7):1177-85. PubMed ID: 12854827
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins: an update on basic biology and clinical relevance.
Schmitt JM; Hwang K; Winn SR; Hollinger JO
J Orthop Res; 1999 Mar; 17(2):269-78. PubMed ID: 10221845
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
19. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells.
Petryk A; Shimmi O; Jia X; Carlson AE; Tervonen L; Jarcho MP; O'connor MB; Gopalakrishnan R
Bone; 2005 Apr; 36(4):617-26. PubMed ID: 15780974
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells.
Biver E; Soubrier AS; Thouverey C; Cortet B; Broux O; Caverzasio J; Hardouin P
Biochem Biophys Res Commun; 2012 Nov; 427(4):737-42. PubMed ID: 23044416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
